EWSR1 Immunotherapy in Ewing Sarcoma and DSRCT

Clinical trial NCT07695311 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07695311
Sponsor: Rabi Hanna
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Ewing Sarcoma Desmoplastic Small Round Cell Tumor

Start date: 2026-10-01
Primary completion: 2029-10-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.